MARSHALL WACE LLP
Q3 2021 Form 13-F

LONDON
CIK 0001318757 · CRD 160885 · Exempt reporting adviser
Consolidated report · includes 4 managers since Q1 2014
$24.1B Reported Value Total
Exempt Reporting Adviser
Source: Form ADV filed 2026-05-29
Reported value
$24.1B
Quarter over quarter
-1.6%
Holdings
2,327
Top-10 concentration
10.5%

Filing Structure

Reports holdings for

  • Marshall Wace North America L P · File #028-11377 · since Q1 2014
  • MARSHALL WACE ASIA Ltd · File #028-14472 · since Q1 2014
  • MARSHALL WACE SINGAPORE PTE LTD (not a 13F filer in our records) · File #028-25074 · since Q4 2024
  • Marshall Wace Middle East Ltd (not a 13F filer in our records) · File #028-25069 · since Q4 2024
  • Lyxor Asset Management Inc. (not a 13F filer in our records) · File #028-18127 · Q3 2018 – Q3 2022 · declared by one filing

Holdings reported by

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Eric Siegel
Operations Manager

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2021 13F record

Q3 2021 13F filing summary

Q3 2021 Form 13F portfolio summary
Period of report September 30, 2021
Filed November 15, 2021
Form 13F-HR
Reported value $24.1B
Positions 2,327
Change in reported value +8.9%
New positions 972
Exited positions 682
Position turnover 55.0%
Top-10 concentration 10.5%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 13, 2026
2,697 $126.7B
Q1 2026 13F
Filed May 15, 2026
2,655 $100.4B
Q4 2025 13F
Filed Feb 13, 2026
2,493 $109.9B
Q3 2025 13F
Filed Nov 13, 2025
2,424 $98.6B
Q2 2025 13F
Filed Aug 13, 2025
2,455 $88.8B
Q1 2025 13F
Filed May 15, 2025
2,402 $78.8B
Q4 2024 13F
Filed Feb 13, 2025
2,298 $83.2B
Q3 2024 13F
Filed Nov 14, 2024
2,213 $82.1B
Q2 2024 13F
Filed Aug 14, 2024
2,219 $74.9B
Q1 2024 13F
Filed May 15, 2024
2,049 $65.7B
Q4 2023 13F
Filed Feb 14, 2024
1,750 $59.0B
Q3 2023 13F
Filed Nov 14, 2023
1,759 $49.4B
Q2 2023 13F
Filed Aug 14, 2023
1,911 $51.2B
Q1 2023 13F
Filed May 15, 2023
2,039 $47.1B
Q4 2022 13F
Filed Feb 14, 2023
2,231 $44.5B
Q3 2022 13F
Filed Nov 14, 2022
2,456 $45.6B
Q2 2022 13F
Filed Aug 15, 2022
2,598 $48.6B
Q1 2022 13F
Filed May 16, 2022
2,511 $52.8B
Q4 2021 13F
Filed Feb 14, 2022
3,069 $54.2B
Q3 2021 13F
Filed Nov 15, 2021
2,327 $24.1B

31 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2021

Largest Q3 2021 13F positions by reported value
# Holding Reported value % of portfolio
1 BHVN BIOHAVEN PHARMAC $377.6M 1.57%
2 BIO BIO-RAD LABS-A $327.7M 1.36%
3 MSFT MICROSOFT CORP $268.6M 1.12%
4 TFX TELEFLEX INC $259.4M 1.08%
5 IWM C December 21 Calls on IWM US at 230, American $252.4M 1.05%
6 ABNB AIRBNB INC-A $234.4M 0.97%
7 TMO THERMO FISHER $230.7M 0.96%
8 AMZN AMAZON.COM INC $221.7M 0.92%
9 GLD P March 22 Puts on GLD US at 151, American $177.8M 0.74%
10 ACN ACCENTURE PLC-A $175.1M 0.73%
11 AAPL APPLE INC $171.9M 0.71%
12 GLD C March 22 Calls on GLD US at 171, American $166.6M 0.69%
13 SGEN SEAGEN INC $162.4M 0.67%
14 NTRA NATERA INC $151.5M 0.63%
15 RGEN REPLIGEN CORP $150.3M 0.62%
16 UBER UBER TECHNOLOGIE $141.6M 0.59%
17 CP CANADIAN PACIFIC $140.0M 0.58%
18 IWM P January 22 Puts on IWM US at 223, American $133.7M 0.56%
19 CRL CHARLES RIVER LA $124.8M 0.52%
20 TLT C October 21 Calls on TLT US at 153, American $120.5M 0.5%

Values as reported on the Q3 2021 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings